Rare diseases
Investigational molecules
Locations
Back to Italy39 clinical trials in Peschiera Del Garda, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Phase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer
ItalyPhase III Randomized Study of Rilvegostomig vs. Pembrolizumab with Platinum-based Chemotherapy in PD-L1 Expressing Metastatic Squamous NSCLC
ItalyStudy of BNT327 with etoposide and carboplatin compared to atezolizumab with etoposide and carboplatin for patients with untreated extensive-stage small-cell lung cancer
ItalyStudy of personalized treatment using drug combination therapy for young women with early stage hormone receptor-positive breast cancer based on gene expression testing
ItalyStudy on the Safety and Effectiveness of BNT327 with Chemotherapy for Patients with Non-Small Cell Lung Cancer
ItalyStudy comparing rilvegostomig plus chemotherapy versus pembrolizumab plus chemotherapy for first-line treatment in patients with metastatic non-squamous lung cancer with PD-L1 expression
ItalyStudy on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis
ItalyAdjuvant Therapy with RO7435846 (divarasib) versus Pembrolizumab or Nivolumab or Observation in Patients After Surgery for Stage II‑III KRAS G12C NSCLC
ItalyEIK1001, Pembrolizumab, and Chemotherapy for Stage 4 Non-Small Cell Lung Cancer in Patients with Stage 4 Non-Small Cell Lung Cancer
ItalyStudy of xaluritamig plus abiraterone for men with metastatic castration-resistant prostate cancer who have not received chemotherapy
ItalyA Study of Belzutifan and Zanzalintinib Compared to Cabozantinib in Patients with Advanced Kidney Cancer that Returned After Previous Treatment
ItalyItalyThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), evaluating novel combination therapies and immunotherapy approaches.
Multiple trials investigating targeted therapies in combination with chemotherapy for improved patient outcomes.
Innovative research examining ER+/HER2- breast cancer treatments, with particular focus on preventing distant metastasis and improving survival rates.
Studies evaluating new therapeutic approaches for early-stage breast cancer patients.
Research focusing on metastatic colorectal cancer treatment strategies, particularly in patients with specific genetic profiles.
Studies comparing continuous versus intermittent treatment protocols for optimal patient outcomes.
Investigation of therapeutic cancer vaccines and novel drug combinations across various cancer types.
Focus on developing personalized treatment approaches based on specific genetic markers.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
